News & Articles
Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Valley Diagnostics and Sona Nanotech sign Heads of Terms agreement to advance commercialization of Bovine TB Assay
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
Bruker announces majority acquisition of RECIPE, a leading provider of mass spectrometry-based diagnostic assay kits for therapeutic drug monitoring
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
Thermo Fisher Scientific opens Advanced Therapies Collaboration Center in Greater San Diego to help accelerate cell therapy development
Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization
Tebubio unveils a reimagined website for life sciences & biotechnology researchers
Explore streamlined navigation, personalized recommendations, and expert support for preclinical products and research services.
LGC Group and Dynamic Devices announce strategic partnership to enhance genomic solutions
The partnership aims to deliver instruments, reagents, and consumables to service laboratories, breeders, and researchers worldwide.
Bold Therapeutics presents poster on BOLD-100 at AACR Annual Meeting 2025
Poster explores BOLD-100's unique ability to mitigate oxaliplatin-induced peripheral neuropathy (OIPN)
Breakthrough result in Hungarian cancer research – Deuterium depletion as a complementary therapy can drastically reduce cancer mortality, increases survival probability
Hungarian researchers have published their latest findings in the prestigious international journal Biomedicines. They show that deuterium depletion, when used as a complementary therapy in cancer treatment, can significantly increase patient survival rates and reduce cancer-related mortality by 75-80%.
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital PCR technology
A fifth of global farmland contaminated by toxic metals, study reveals
Scientists warn of major risks to food security and public health as soil pollution spreads worldwide
Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits
Two ELISA kits for diagnostics and two for research
ELRIG announces new leadership to drive continued growth and collaboration in drug discovery
ELRIG appoints Dr. Del Trezise as Chair of the Board
Industry leaders address future of oncology drugs and biotech funding at AAPS National Biotechnology Conference
Registration now open
Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care
Interoperable AI-powered digital pathology workflows support confident cancer diagnosis
Grifols and Inpeco join forces to deliver transfusion medicine ‘lab of the future’
The broader diagnostic capabilities enhance Grifols leadership in developing and providing a complete set of automation solutions that optimize operations regardless of size, from small labs to large blood banks
New strategy against coronaviruses
Researchers at the University of Bern have analyzed a mechanism by which the coronavirus manipulates human cells to replicate itself
Integrated DNA Technologies and Elegen partner to revolutionize long DNA synthesis market
Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb
Pittcon returns to its roots
In 2027, the Pittsburgh Conference and Exhibition returns to Pittsburgh after 60 years